Literature DB >> 12966455

[Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics: a discussion of three cases].

F Llinares Tello1, N Bosacoma Ros, C Hernández Prats, E Climent Grana, J Selva Otaolaurruchi, J P Ordovás Baines.   

Abstract

A number of literature references suggest that carbapenem-like antibiotics decrease plasma concentrations of valproic acid in epileptic patients. This interaction may result in a recurrence of epileptic seizures in these patients. To clarify the possible mechanism of such carbapenem-valproic acid interaction several experimental studies have been carried out in animals. However, the mechanism of this drug-drug interaction is as yet uncertain. in this article we report three new cases that were observed in our hospital within three months. One of these patients developed seizures. We also review the different mechanisms proposed, as well as cases published to this day. All these data demonstrate that care should be taken in using these potent antibiotics in patients receiving valproic acid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966455

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  3 in total

1.  Pharmacokinetic interaction between valproic acid and meropenem.

Authors:  Didier Clause; Pierre-Yves Decleire; Roger Vanbinst; Aurélie Soyer; Philippe Hantson
Journal:  Intensive Care Med       Date:  2005-06-14       Impact factor: 17.440

2.  Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications.

Authors:  Carla Carnovale; Marco Pozzi; Faizan Mazhar; Giulia Mosini; Marta Gentili; Gabriëlla G A M Peeters; Emilio Clementi; Sonia Radice
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

3.  Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.

Authors:  Hiroaki Ikeda; Teruo Murakami; Mikihisa Takano; Tsuguru Usui; Kenji Kihira
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.